MicroAire: Expanding Adipose Tissue Market Leadership with NEOSYAD Acquisition
Deal News | Jan 20, 2025 | PR Newswire Cision MicroAire
MicroAire Surgical Instruments, a leader in power-assisted liposuction, has announced the acquisition of NEOSYAD, a medical device company known for its innovative technology in adipose tissue engineering. NEOSYAD has received EU MDR approval for its AdiMate® device and Adipure® single-use kit, which enhances operating times and adipose tissue quality. The acquisition aligns with MicroAire's strategy to bolster its leadership in the adipose tissue market by incorporating NEOSYAD's technology into its offerings. Both companies express enthusiasm over the merger, seeing it as an opportunity to scale NEOSYAD's groundbreaking solutions and offer better patient outcomes globally. The strategic acquisition is expected to position MicroAire for accelerated growth and innovation in the field.
Sectors
- Medical Devices
- Healthcare
Geography
- United States – MicroAire, the acquiring company, is based in Charlottesville, Virginia, and is a significant player in the U.S. adipose tissue market.
- Europe – NEOSYAD's recent EU MDR approval indicates a geographic focus on the European medical device market, crucial for the strategic expansion of MicroAire.
Industry
- Medical Devices – This industry encompasses the development and manufacturing of devices that aid in medical procedures, relevant due to MicroAire's and NEOSYAD's focus on adipose tissue engineering technologies.
- Healthcare – A broader industry involving services, products, and operations aimed at enhancing health outcomes, relevant here as the acquisition impacts surgical procedures and patient care in adipose tissue treatments.
Financials
- – The article does not disclose specific financial terms of the acquisition.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| MicroAire Surgical Instruments | Acquirer | Company | A global leader in power-assisted liposuction devices, expanding its market presence through strategic acquisitions. |
| NEOSYAD | Target company | Company | An innovative medical device company specializing in adipose tissue engineering technology. |
| Jerome Barrillon | President | Person | President of MicroAire, overseeing the strategic acquisition of NEOSYAD. |
| Regis Roche | Co-founder and President | Person | Co-founder and President of NEOSYAD, involved in steering the company towards this strategic partnership. |
| David Kraus | Senior Director, Strategy & Customer Excellence | Person | Media contact for MicroAire, involved in strategic communications. |